Exclude Patient Type Detail Header
No
Footnote
<sup>30</sup> Offer vaccine prior to onset of influenza circulation in community, or soon after vaccine is available (by October, if possible), and continue to offer it as long as influenza viruses are circulating.<br><br><sup>31</sup> RIV3 contraindications: Severe allergic rxn to any vaccine component.
<br><br><sup>32</sup> RIV3 precautions: Mod to severe illness w/ or w/o fever, hx of GBS w/in 6 wks of receipt of influenza vaccine.
<br><br><sup>33</sup> IIV contraindications: Severe allergic rxn to any vaccine component (incl. egg) or after previous dose of any influenza vaccine.
<br><br><sup>34</sup> IIV precautions: Mod to severe illness w/ or w/o fever, hx of GBS w/in 6 wks of receipt of influenza vaccine.
<br><br><sup>35</sup> Regardless of allergy hx, all vaccines should be administered in settings w/ personnel & equipment for rapid recognition and tx of anaphylaxis.
<br><br><sup>32</sup> RIV3 precautions: Mod to severe illness w/ or w/o fever, hx of GBS w/in 6 wks of receipt of influenza vaccine.
<br><br><sup>33</sup> IIV contraindications: Severe allergic rxn to any vaccine component (incl. egg) or after previous dose of any influenza vaccine.
<br><br><sup>34</sup> IIV precautions: Mod to severe illness w/ or w/o fever, hx of GBS w/in 6 wks of receipt of influenza vaccine.
<br><br><sup>35</sup> Regardless of allergy hx, all vaccines should be administered in settings w/ personnel & equipment for rapid recognition and tx of anaphylaxis.
Detail Type
Text